Minireviews
Copyright ©The Author(s) 2018.
World J Transplant. Jun 28, 2018; 8(3): 61-67
Published online Jun 28, 2018. doi: 10.5500/wjt.v8.i3.61
Table 2 Advantages and limitations of some commercially available (minimally invasive) cardiac output monitoring[19,20]
ModalityExamplesAdvantagesLimitations
Pulse wave analysisLiDCOrapid™ and FloTrac/Vigileo™Requires only arterial line; Beat-by-beat CO monitoring (this may help to evaluate response to IV fluids). - Validated by clinical studies in different medical and surgical conditionsPresence of arterial line with optimum waveform signal is a prerequisite; Accuracy may be reduced by sever arrhythmia; Needs frequent recalibration during periods of hemodynamic Instability
Lithium dilutionLiDCOplusSimple technique (can use peripheral arterial line); Continuous CO monitoringArterial line required; Accuracy affected by some neuromuscular blocking drugs; Lithium chloride is contraindicated in patients undergoing treatment with lithium salts
Electrical bioimpedanceBioZ®Completely non-invasiveNumerous mathematical assumptions; Limited validity in patients with dysrhythmias
Partial CO2 rebreathingNICO™Easy to set upRequires intubation and mechanical ventilation with minimal gas exchange abnormalities and fixed ventilator settings; Accuracy decreased with haemodynamic instability
Pulsed dye densitometryDDG-330®Non-invasiveIntermittent assessment; Accuracy may be affected by vasoconstriction, movement of the sensor and interstitial oedema